2013 Japanese Microbiology Testing Market: Opportunities and Strategies for Suppliers
Upcoming SlideShare
Loading in...5
×
 

2013 Japanese Microbiology Testing Market: Opportunities and Strategies for Suppliers

on

  • 387 views

 

Statistics

Views

Total Views
387
Views on SlideShare
387
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

2013 Japanese Microbiology Testing Market: Opportunities and Strategies for Suppliers 2013 Japanese Microbiology Testing Market: Opportunities and Strategies for Suppliers Document Transcript

  • 2013 Japanese Microbiology Testing Market: Opportunities andStrategies for SuppliersReport Details:Published:January 2013No. of Pages: 976Price: Single User License – US$7800Highlights•Major issues pertaining to the Japanese microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.•Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in Japanese hospitals, blood banks and commercial laboratories.•Instrumentation technologies and feature comparison of leading analyzers.•Sales and market shares of leading suppliers.•Emerging diagnostic technologies and their potential market applications.•Product development opportunities.•Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Business opportunities and strategic recommendations for suppliers.Get your copy of this report @http://www.reportsnreports.com/reports/213578-2013-japanese-microbiology-testing-market-opportunities-and-strategies-for-suppliers.htmlMajor points covered in Table of Contents of this report includeTable of ContentsIntroductionWorldwide Market and Technology OverviewA. Major Infectious Disease Tests1. AIDSa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs
  • 2. Adenovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugsd. Adeno-Associated Viruses(AAV)3. Aeromonasa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs4. Anthrax/Bacillus Anthracisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs5. Arbovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs6. Babesiosisa. Background7. Bacillary Epithelioid Angiomatosis (BEA)And Other Bartonella (Rochalimaea)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs8. Blastocystis Hominisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs9. Brucellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs10. Campylobactera. Backgroundb. Diagnostic Testsc. Vaccines and Drugs11. Candidaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs12. Chagas Diseasea. Background
  • 13. Chancroida. Backgroundb. Diagnostic Testsc. Vaccines and Drugs14. Chlamydiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs15. Clostridium Difficilea. Backgroundb. Diagnostic Testsc. Drugs and Vaccines16. Coronavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs17. Coxsackievirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs18. Creutzfeldt-Jakob’s Diseasea. Backgroundb. Diagnostic Testsc. Vaccine19. Cryptosporidium Parvuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs20. Cyclospora Cayetanensisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs21. Cytomegalovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs22. Ebola Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs23. E. Colia. Background
  • b. Diagnostic Testsc. Vaccines and Drugs24. EchoVirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs25. Encephalitisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs26. Enterovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs27. Epstein-Barr Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs28. Giardia Lambliaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs 29. Gonorrheaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs30. Granuloma Inguinalea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs31. Hantavirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs32. Helicobacter Pyloria. Backgroundb. Diagnostic Testsc. Vaccines and Drugs33. Hepatitisa. Backgroundb. Hepatitis Ac. Hepatitis B
  • d. Hepatitis Ce. Vaccines and Drugs34. Herpes Simplex Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs35. Human Herpes Virus-6 (HHV-6)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs36. Influenza Virusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs37. Legionellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs38. Lyme Diseasea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs39. Lymphogranuloma Venereum (LGV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs40. Malariaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs41. Measles (Rubeola)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs42. Meningitisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs43. Microsporidiuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs
  • 44. Mononucleosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs45. Mumpsa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs46. Mycoplasmaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs47. Papillomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs48. Parvovirus B19a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs49. Pneumoniaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs50. Polyomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs51. Pseudomonas Aeruginosaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs52. Rabiesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs53. Respiratory Syncytial Virus (RSV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs54. RhinoVirusesa. Background
  • b. Diagnostic Testsc. Vaccines and Drugs55. RotaVirus (REOVIRUS)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs56. Rubella(MEASLES)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs57. Salmonellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs58. Septicemiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs59. Shigellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs60. Staphylococcus Aureusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs61. Streptococcia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs62. Syphilisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs63. Toxoplasmosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs64. Trichomonas Vaginalisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs
  • 65. Tuberculosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs66. Vibrioa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs67. West Nile Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs68. Yersinaa. Backgroundb. Diagnostic Testsc. Vaccines and DrugsB. Instrumentation Review of Leading Analyzers Marketed by Abbott, BeckmanCoulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallacand Other SuppliersC. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherJapanA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. InstrumentationB. Reagent Kits and Test Systems/PanelsC. Computers, Software and AutomationD. Auxiliary Products
  • Design Criteria for Decentralized Testing Products Alternative Market PenetrationStrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive AssessmentsAbbottAffymetrixBeckman Coulter/DanaherBecton DickinsonbioMerieuxBio-RadCepheidDiamedixDiaSorinEiken ChemicalEnzo BiochemFujirebioGen-ProbeHologicID BiomedicalInnogenetics/SolvayKreatechLife TechnologyLonzaNanogen/Elitech
  • Novartis DiagnosticsOrtho-Clinical DiagnosticsQiagenRocheScienionSequenomSeraCareSiemensTakara BioThermo FisherWallacWakoList of TablesMajor Companies Developing or Marketing AIDS TestsMajor Companies Developing or Marketing Adenovirus TestsMajor Companies Developing or Marketing Bartonella TestsMajor Companies Developing or Marketing Campylobacter TestsMajor Companies Developing or Marketing Candida TestsMajor Companies Developing or Marketing Chlamydia TestsMajor Companies Developing or Marketing Clostridium TestsMajor Companies Developing or Marketing Coronavirus TestsMajor Companies Developing or Marketing Cryptosporidium TestsMajor Companies Developing or Marketing CMV TestsMajor Companies Developing or Marketing Echovirus TestsMajor Companies Developing or Marketing Enterovirus TestsMajor Companies Developing or Marketing EBV TestsMajor Companies Developing or Marketing Giardia TestsMajor Companies Developing or Marketing Gonorrhea TestsMajor Companies Developing or Marketing Hantavirus TestsMajor Companies Developing or Marketing Helicobacter Pylori TestsMajor Companies Developing or Marketing Hepatitis TestsMajor Companies Developing or Marketing Herpes TestsMajor Companies Developing or Marketing Influenza TestsMajor Companies Developing or Marketing Legionella TestsMajor Companies Developing or Marketing Lyme Disease TestsMajor Companies Developing or Marketing Lymphogranuloma TestsMajor Companies Developing or Marketing Malaria TestsMajor Companies Developing or Marketing Measles TestsMajor Companies Developing or Marketing Meningitis TestsMajor Companies Developing or Marketing Microsporidium TestsMajor Companies Developing or Marketing Mononucleosis TestsMajor Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma TestsMajor Companies Developing or Marketing Papilloma Virus TestsMajor Companies Developing or Marketing Parvovirus TestsMajor Companies Developing or Marketing Pneumonia TestsMajor Companies Developing or Marketing RSV TestsMajor Companies Developing or Marketing Rotavirus TestsMajor Companies Developing or Marketing Rubella TestsMajor Companies Developing or Marketing Salmonella TestsMajor Companies Developing or Marketing Septicemia TestsMajor Companies Developing or Marketing Shigella TestsMajor Companies Developing or Marketing Staphylococci TestsMajor Companies Developing or Marketing Streptococci TestsMajor Companies Developing or Marketing Syphilis TestsMajor Companies Developing or Marketing Toxoplasmosis TestsMajor Companies Developing or Marketing Trichomonas TestsMajor Companies Developing or Marketing Tuberculosis TestsMajor Companies Developing or Marketing West Nile TestsMajor Companies Developing or Marketing Yersinia TestsJapan Summary TableAll Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Laboratories Performing Infectious Disease Tests by Market SegmentJapan Hospital Laboratories Performing Infectious Disease Tests by Bed SizeJapan Commercial/Private Laboratories Performing Infectious Disease Tests by Annual TestVolumeJapan All Market Segments Infectious Disease Test Volume ForecastJapan Hospital Laboratories Infectious Disease Test Volume ForecastJapan Blood Banks Infectious Disease Test Volume ForecastJapan Commercial/Private Laboratories Infectious Disease Test Volume ForecastJapan All Market Segments Infectious Disease Diagnostics Market ForecastJapan Hospital Laboratories Infectious Disease Diagnostics Market ForecastJapan Blood Banks Infectious Disease Diagnostics Market ForecastJapan Commercial/Private Laboratories Infectious Disease Diagnostics Market ForecastJapan HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market SegmentJapan HIV Ag Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by MarketSegmentJapan Adenovirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Aeromonads Test Volume and Diagnostics Sales Forecast by Market SegmentJapan BEA Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Campylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Candida Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan Chancroid Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Chlamydia Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Clostridium Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Coronavirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Coxsackievirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentJapan CMV Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Cyclospora Test Volume and Diagnostics Sales Forecast by Market SegmentJapan E. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Echovirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Encephalitis Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Enterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan EBV Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Giardia Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Gonorrhea Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Hantavirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market SegmentJapan HBsAg Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Hepatitis C Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Anti-HBc Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Anti-HBs Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Anti-HAV Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market SegmentJapan HAV NAT Test Volume and Diagnostics Sales Forecast by Market SegmentJapan HBV NAT Test Volume and Diagnostics Sales Forecast by Market SegmentJapan HBcAg Test Volume and Diagnostics Sales Forecast by Market SegmentJapan HBeAg Test Volume and Diagnostics Sales Forecast by Market SegmentJapan ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market SegmentJapan HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Influenza Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Legionella Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Lyme Disease Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Malaria Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Measles Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Meningitis Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Microsporidium Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Mononucleosis Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan Mycoplasma Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Parvovirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Pneumonia Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Polyoma Viruses Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Pseudomonas Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Rabies Test Volume and Diagnostics Sales Forecast by Market SegmentJapan RSV Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Rhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Rotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Rubella Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Salmonella Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Septicemia Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Shigella Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Staphylococci Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Streptococci Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Syphilis Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Trichomonas Test Volume and Diagnostics Sales Forecast by Market SegmentJapanTuberculosis Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Vibrio Test Volume and Diagnostics Sales Forecast by Market SegmentJapan Yersinia Test Volume and Diagnostics Sales Forecast by Market SegmentJapan AIDS Testing Market Diagnostics Sales by Major SupplierJapan Adenovirus Testing Market Diagnostics Sales by Major SupplierJapan Campylobacter Testing Market Diagnostics Sales by Major SupplierJapan Candida Testing Market Diagnostics Sales by Major SupplierJapan Chlamydia Testing Market Diagnostics Sales by Major SupplierJapan CMV Testing Market Diagnostics Sales by Major SupplierJapan Gonorrhea Testing Market Diagnostics Sales by Major SupplierJapan Hepatitis Testing Market Diagnostics Sales by Major SupplierJapan Hepatitis C Testing Market Diagnostics Sales by Major SupplierJapan Herpes Testing Market Diagnostics Sales by Major SupplierJapan Lyme Disease Testing Market Diagnostics Sales by Major SupplierJapan Influenza Testing Market Diagnostics Sales by Major SupplierJapan Meningitis Testing Market Diagnostics Sales by Major SupplierJapan Mononucleosis Testing Market Diagnostics Sales by Major SupplierJapan Mumps Testing Market Diagnostics Sales by Major SupplierJapan Mycoplasma Testing Market Diagnostics Sales by Major SupplierJapan RSV Testing Market Diagnostics Sales by Major SupplierJapan Rotavirus Testing Market Diagnostics Sales by Major SupplierJapan Rubella Testing Market Diagnostics Sales by Major SupplierJapan Septicemia Testing Market Diagnostics Sales by Major Supplier
  • Japan Shigella Testing Market Diagnostics Sales by Major SupplierJapan Streptococci Testing Market Diagnostics Sales by Major SupplierJapan Syphilis Testing Market Diagnostics Sales by Major SupplierJapan Toxoplasmosis Testing Market Diagnostics Sales by Major SupplierJapan Trichomonas Testing Market Diagnostics Sales by Major SupplierJapan Tuberculosis Testing Market Diagnostics Sales by Major SupplierContact: sales@reportsandreports.com for more information.